SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Feb-24 4:32 PM View: | Annexon, Inc. (ANNX) | 16-Feb-24 | Grant | 39,000 | -- | -- | 100% 0 to 39.0K | |
03-Apr-23 4:51 PM View: | Unity Biotechnology, Inc. (UBX) | 31-Mar-23 | Private Sale (Planned) | 420 | $1.70 | $714.00 | (< 1%) 63.24K to 62.82K | |
15-Mar-23 5:02 PM View: | Unity Biotechnology, Inc. (UBX) | 14-Mar-23 | Private Sale (Planned) | 1,005 | $4.00 | $4,020.00 | (2%) 64.24K to 63.24K | |
03-Feb-23 4:33 PM View: | Unity Biotechnology, Inc. (UBX) | 02-Feb-23 | Private Sale (Planned) | 863 | $4.84 | $4,176.92 | (1%) 65.11K to 64.24K | |
15-Dec-22 4:44 PM View: | Unity Biotechnology, Inc. (UBX) | 14-Dec-22 | Private Sale (Planned) | 1,016 | $2.85 | $2,895.60 | (2%) 66.12K to 65.11K | |
15-Sep-22 4:10 PM View: | Unity Biotechnology, Inc. (UBX) | 14-Sep-22 | Sale (Planned) | 10,923 | $0.48 | $5,243.04 | (2%) 672.14K to 661.21K | |
28-Jun-22 6:11 PM View: | Unity Biotechnology, Inc. (UBX) | 27-Jun-22 | Sale (Planned) | 4,398 | $0.59 | $2,594.82 | (< 1%) 676.53K to 672.14K | |
22-Jun-22 4:49 PM View: | Unity Biotechnology, Inc. (UBX) | 21-Jun-22 | Sale (Planned) | 3,697 | $0.62 | $2,292.14 | (< 1%) 680.23K to 676.53K | |
15-Jun-22 4:34 PM View: | Unity Biotechnology, Inc. (UBX) | 14-Jun-22 | Payment of Exercise | 10,530 | $0.63 | $6,633.90 | (2%) 690.76K to 680.23K | |
01-Apr-22 4:24 PM View: | Unity Biotechnology, Inc. (UBX) | 31-Mar-22 | Payment of Exercise | 4,188 | $1.14 | $4,774.32 | (< 1%) 694.95K to 690.76K | |
15-Mar-22 4:53 PM View: | Unity Biotechnology, Inc. (UBX) | 14-Mar-22 | Payment of Exercise | 10,581 | $0.88 | $9,311.28 | (1%) 705.53K to 694.95K | |
15-Feb-22 5:23 PM View: | Unity Biotechnology, Inc. (UBX) | 09-Feb-22 | Grant | 45,833 | -- | -- | 7% 659.7K to 705.53K | |
15-Dec-21 4:26 PM View: | Unity Biotechnology, Inc. (UBX) | 14-Dec-21 | Payment of Exercise | 10,614 | $1.63 | $17,300.80 | (2%) 670.31K to 659.7K | 3% |
28-Jun-21 5:16 PM View: | Unity Biotechnology, Inc. (UBX) | 24-Jun-21 | Grant | 25,000 | -- | -- | 4% 685.88K to 710.88K | |
23-Jun-21 5:03 PM View: | Unity Biotechnology, Inc. (UBX) | 21-Jun-21 | Payment of Exercise | 3,515 | $4.18 | $14,692.70 | (< 1%) 689.39K to 685.88K | < 1% |
01-Apr-21 5:13 PM View: | Unity Biotechnology, Inc. (UBX) | 30-Mar-21 | Payment of Exercise | 2,829 | $5.73 | $16,210.20 | (< 1%) 692.22K to 689.39K | (5%) |
01-Oct-21 9:57 PM View: | Unity Biotechnology, Inc. (UBX) | 30-Mar-21 | Payment of Exercise | 40,564 | $2.95 | $119,664.00 | (6%) 710.88K to 670.31K | |
15-Sep-20 9:01 PM View: | Unity Biotechnology, Inc. (UBX) | 13-Sep-20 | Grant | 240,000 | -- | -- | 53% 452.22K to 692.22K | |
24-Jun-20 4:59 PM View: | Unity Biotechnology, Inc. (UBX) | 22-Jun-20 | Payment of Exercise | 2,483 | $9.67 | $24,010.60 | (< 1%) 454.7K to 452.22K | 42% |
01-Apr-20 5:08 PM View: | Unity Biotechnology, Inc. (UBX) | 30-Mar-20 | Grant | 24,255 | -- | -- | 6% 430.45K to 454.7K | |
24-Jun-19 4:17 PM View: | Unity Biotechnology, Inc. (UBX) | 20-Jun-19 | Grant | 21,075 | -- | -- | 5% 409.37K to 430.45K | |
07-May-18 6:20 PM View: | Unity Biotechnology, Inc. (UBX) | 07-May-18 | Conversion | 75,678 | -- | -- | 23% 333.69K to 409.37K |